S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
BREAKING: Tiny biotech successfully treats blindness (Ad)
Berlin climate proposal fails to get enough yes votes to win
Adele extends Las Vegas residency, plans concert film
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
BREAKING: Tiny biotech successfully treats blindness (Ad)
Berlin climate proposal fails to get enough yes votes to win
Adele extends Las Vegas residency, plans concert film
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
BREAKING: Tiny biotech successfully treats blindness (Ad)
Berlin climate proposal fails to get enough yes votes to win
Adele extends Las Vegas residency, plans concert film
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
BREAKING: Tiny biotech successfully treats blindness (Ad)
Berlin climate proposal fails to get enough yes votes to win
Adele extends Las Vegas residency, plans concert film
OTCMKTS:ARYC

Arrayit - ARYC Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1 shs
Average Volume
35,000 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ARYC stock logo

About Arrayit (OTCMKTS:ARYC) Stock

Arrayit Corp. engages in developing, manufacturing and marketing life science tools and integrated systems for the analysis of genetic variation, biological function and diagnostics. Its products include microarrayers, Microarray Scanners, DNA Microarrays, Protein Microarrays, Microarray Printing, Microarray Substrate Slides, Microarray Instrument, Amplification & Labeling, purification kits, Microarray Tools, buffers and solutions, microarray Cleanrooms, Books & software, CGH Microarrays and Microarray Platforms. The company provides tools and services to genomic research centres, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies. Arrayit was founded by Todd J. Martinsky in November 1999 and is headquartered in Sunnyvale, CA.

Receive ARYC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arrayit and its competitors with MarketBeat's FREE daily newsletter.

ARYC Stock News Headlines

The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
Arrayit Corporation (ARYC)
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
News for Arrayit Corp
See More Headlines
Receive ARYC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arrayit and its competitors with MarketBeat's FREE daily newsletter.

ARYC Company Calendar

Today
3/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ARYC
Employees
7
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.48

Key Executives

  • Rene A. Schena
    Chairman & Chief Executive Officer
  • Mark Schena
    President, Secretary, Treasurer & Director
  • Todd J. Martinsky
    Director, Chief Technology Officer & EVP













ARYC Stock - Frequently Asked Questions

What other stocks do shareholders of Arrayit own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Arrayit investors own include Western Alliance Bancorporation (WAL), Mr. Cooper Group (COOP), Pacific Biosciences of California (PACB), WMIH (WMIH), Actinium Pharmaceuticals (ATNM), MICT (MICT), PolyMet Mining (PLM), Uni-Pixel (UNXLQ) and

What is Arrayit's stock symbol?

Arrayit trades on the OTCMKTS under the ticker symbol "ARYC."

How do I buy shares of Arrayit?

Shares of ARYC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How can I contact Arrayit?

Arrayit's mailing address is 927 THOMPSON PLACE, SUNNYVALE CA, 94085. The official website for the company is www.arrayit.com. The company can be reached via phone at (408) 744-1331, via email at investorrelations@arrayit.com, or via fax at 408-744-1711.

This page (OTCMKTS:ARYC) was last updated on 3/26/2023 by MarketBeat.com Staff